Effects of methimepip and JNJ-5207852 in Wistar rats exposed to an open-field with and without object and in Balb/c mice exposed to a radial-arm maze

Frontiers in Systems Neuroscience

Volumn , Issue JULY 2012, 2012, Pages

  Abuhamdah, Rushdie M A ^a   van Rensburg, Ruan ^a,b   Lethbridge, Natasha L ^a   Ennaceur, Abdel ^c   Chazot, Paul L ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

3D maze; Anxiety; Avoidance; Fear; Histamine; Object novelty

Indexed keywords

HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; JNJ 5207852; METHIMEPIP; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BAGG ALBINO MOUSE; BEHAVIORAL SCIENCE; C57BL 6 MOUSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; MALE; MAZE TEST; MOUSE; NONHUMAN; OBJECT MANIPULATION; OPEN FIELD TEST; RAT; SINGLE DRUG DOSE; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE; WISTAR RAT;

EID: 84865012721     PISSN: 16625137     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnsys.2012.00054     Document Type: Article

References (39)

1. Acevedo, S. F., Pfankuch, T., Ohtsu, H., and Raber, J. (2006). Anxiety and cognition in female histidine decarboxylase knockout [Hdc(-/-)] mice. Behav. Brain Res. 168, 92-99.
2. Arrang, J. M., Druetl, G., and Schwartz, J. C. (1995). Characterisation of histamine H3 receptors regulating acetylcholine release in the rat enthorinal cortex. Br. J. Pharmacol. 114, 1518-1522.
3. Arrang, J. M., Garbarg, M., and Schwartz, J. C. (1987). Autoinhibition of histamine synthesis mediated by presynaptic H3 receptors. Neuroscience 23, 149-157.
4. Baldi, E., Bucherelli, C., Schunack, W., Cenni, G., Blandina, P., and Passani, M. B. (2005). The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat. Neuropharmacology 48, 246-251.
5. Barbier, A. J., Berridge, C., Dugovic, C., Laposky, A. D., Wilson, S. J., Boggs, J., Aluisio, L., Lord, B., Mazur, C., Pudiak, C. M., Langlois, X., Xiao, W., Apodaca, R., Carruthers, N. I., and Lovenberg, T. W. (2004). Acute wakepromoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br. J. Pharmacol. 143, 649-661.
6. Blandina, P., Giorgetti, M., Bartolini, L., Cecchi, M., Timmerman, H., Leurs, R., Pepeu, G., and Giovannini, M. G. (1996). Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br. J. Pharmacol. 119, 1656-1664.
7. Bongers, G., Leurs, R., Robertson, J., and Raber, J. (2004). Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe-/ mice. Neuropsychopharmacology 29, 441-449.
8. Buhot, M.-C. (1989). Exploration and choice by mice among nest boxes differing in size: influence of the inner and the outer dimensions. Q. J. Exp. Psychol. B 41, 49-64.
9. Chazot, P. L. (2010). Therapeutic potential of histamine H3 receptor antagonists in dementias. Drug News Perspect. 23, 99-103.
10. Crawley, J. N. (1981). Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol. Biochem. Behav. 15, 695-699.
11. Dere, E., de Souza-Silva, M. A., Spieler, R. E., Lin, J. S., Ohtsu, H., Haas, H. L., and Huston, J. P. (2004). Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur. J. Neurosci. 20, 1051-1058.
12. Dere, E., Zlomuzica, A., de Souza Silva, M. A., Ruocco, L. A., Sadile, A. G., and Huston, J. P. (2010). Neuronal histamine and the interplay of memory, reinforcement and emotions. Behav. Brain Res. 215, 209-220.
13. Ennaceur, A. (2011). Omission of the habituation procedure in the acquisition of a working memory task: evidence from Balbc, C57BL6J, and CD-1 mice. Behav. Brain Res. 223, 203-210.
14. Ennaceur, A. (2012). Open space anxiety test in rodents: the elevated platform with steep slopes. Methods Mol. Biol. 829, 177-191.
15. Ennaceur, A., Michalikova, S., and Chazot, P. L. (2009a). Models of anxiety: responses of rats to novelty in an open space and an enclosed space. Behav. Brain Res. 171, 26-49.
16. Ennaceur, A., Michalikova, S., and Chazot, P. L. (2009b). Do rats really express neophobia towards novel objects? Experimental evidence from exposure to novelty and to an object recognition task in an open space and an enclosed space. Behav. Brain Res. 197, 417-434.
17. Ennaceur, A., Michalikova, S., van Rensburg, R., and Chazot, P. L. (2006). Models of anxiety: responses of mice to novelty and open spaces in a 3D maze. Behav. Brain Res. 174, 9-38.
18. Ennaceur, A., Michalikova, S., van Rensburg, R., and Chazot, P. L. (2008). Are benzodiazepines really anxiolytic: evidence from a 3D maze spatial navigation task. Behav. Brain Res. 188, 136-153.
19. Ennaceur, A., Michalikova, S., van Rensburg, R., and Chazot, P. L. (2010). Distinguishing anxiolysis and hyperactivity in an open space behavioral test. Behav. Brain Res. 207, 84-98.
20. Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D., and Brioni, J. D. (2008). The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br. J. Pharmacol. 154, 1166-1181.
21. Frisch, C., Hasenöhrl, R. U., Krauth, J., and Huston, J. P. (1998). Anxiolytic-like behavior after lesion of the tuberomammillary nucleus E2-region. Exp. Brain Res. 119, 260-264.
22. Giannoni, P., Medhurst, A. D., Passani, M. B., Giovannini, M. G., Ballini, C., Corte, L. D., and Blandina, P. (2010). Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2, 3, 4, 5-tetrahydro-1H3-benzazepin-7-yl)oxy]-N-methyl3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats. J. Pharmacol. Exp. Ther. 332, 164-172.
23. Giannoni, P., Passani, M. B., Nosi, D., Chazot, P. L., Shenton, F. C., Medhurst, A. D., Munari, L., and Blandina, P. (2009). Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat. Eur. J. Neurosci. 29, 2363-2374.
24. Haas, H. L., Sergeeva, O. A., and Selbach, O. (2008). Histamine in the nervous system. Physiol. Rev. 88, 1183-1241.
25. Handley, S. L., and Mithani, S. (1984). Effects of α2-adrenoceptor agonists and antagonists in a maze exploration model of fear-motivated behaviour. Schmiedebergs. Naunyn Schmiedebergs Arch. Pharmacol. 327, 1-5.
26. Hughes, R. N. (2007). Neotic preferences in laboratory rodents: issues, assessment and substrates. Neurosci. Biobehav. Rev. 31, 441-464.
27. Imaizumi, M., and Onodera, K. (1993). The behavioral and biochemical effects of thioperamide, a histamine H3 receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sci. 53, 1675-1683.
28. Jia, F., Kato, M., Dai, H., Xu, A., Okuda, T., Sakurai, E., Okamura, N., Lovenberg, T. W., Barbier, A., Carruthers, N. I., Iinuma, K., and Yanai, K. (2006). Effects of histamine H3 antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice. Neuropharmacology 50, 404-411.
29. Kitbunnadaj, R., Hashimoto, T., Poli, E., Zuiderveld, O. P., Menozzi, A., Hidaka, R., de Esch, I. J., Bakker, R. A., Menge, W. M., Yamatodani, A., Coruzzi, G., Timmerman, H., and Leurs, R. (2005). N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist. J. Med. Chem. 48, 2100-2107.
30. Leurs, R., Vischer, H. F., Wijtmans, M., and de Esch, I. J. (2011). En route to new blockbuster antihistamines: surveying the offspring of the expanding histamine receptor family. Trends Pharmacol. Sci. 32, 250-257.
31. Malin, D. H. (1974). Synthetic scotophobin: analysis of behavioral effects on mice. Pharmacol. Biochem. Behav. 2, 147-153.
32. Michalikova, S., van Rensburg, R., Chazot, P. L., and Ennaceur, A. (2010). Anxiety responses in Balb/c, c57 and CD-1 mice exposed to a novel open space test. Behav. Brain Res. 207, 402-417.
33. Morgan, W. W., and Kamp, C. W. (1980). Dopaminergic amacrine neurons of rat retinas with photoreceptor degeneration continue to respond to light. Life Sci. 26, 1619-1626.
34. Passani, M. B., and Blandina, P. (2011). Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol. Sci. 32, 242-249.
35. Pellow, S., Chopin, P., File, S., and Briley, M. (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167.
36. Pérez-García, C., Morales, L., Cano, M. V., Sancho, I., and Alguacil, L. F. (1999). Effects of histamine H3 receptor ligands in experimental models of anxiety and depression. Psychopharmacology (Berl.) 142, 215-220.
37. Rizk, A., Curley, J., Robertson, J., and Raber, J. (2004). Anxiety and cognition in histamine H3 receptor -/ mice. Eur. J. Neurosci. 19, 1992-1996.
38. Threlfell, S., Cragg, S. J., Kalló, I., Turi, G. F., Coen, C. W., and Greenfield, S. A. (2004). Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J. Neurosci. 24, 8704-8710.
39. Yokoyama, F., Yamauchi, M., Oyama, M., Okuma, K., Onozawa, K., Nagayama, T., Shinei, R., Ishikawa, M., Sato, Y., and Kakui, N. (2009). Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Psychopharmacology (Berl.) 205, 177-187.